Jump to content
  • Summer Sale

    20% off elearning, remote and f2f courses and webcasts - use code SUMMER2021

    More Information
  • Exhibit with us for free

    Become a 2022 conference exhibitor and join us in 2021 for no charge.

    More Information
  • Become a Member

    You can now apply for RQA membership online.

    Join Now

Who are RQA

The Research Quality Association (RQA) is a professional membership body dedicated to informing and advancing its members. We provide status and visibility for individuals engaged in the quality of research concerning pharmaceuticals, agrochemicals, chemicals and medical devices. Since our inception in 1977, the Association has increased and evolved to reflect regulatory changes, the growing impact of regulatory inspection and the ever-changing structure and needs of industry. RQA's purpose is to drive quality and integrity in scientific research.  

Read more+

Our vision

To inspire quality, integrity and compliance in scientific research.

Our mission

To provide knowledge and learning in the scientific research community by building expertise through training, communication, engagement and collaboration.

Newsletter

Sign up to the latest news and events.

Latest News

View all news

EMA - Reflection paper on Good Manufacturing Practice and Marketing Authorisation Holders

Reflection paper on Good Manufacturing Practice and Marketing Authorisation Holders - now available.

Read more+

BMJ - The review of the global first SARS COV 2 Human Infection Challenge studies

Expert and lay members of UK RECs recognised to review Clinical Trials of Investigational Medicinal Products (CTIMPs) or Phase 1 studies in healthy volunteers, particularly those with experience of vaccine studies, were invited to join an ad hoc Research Ethics Committee to review SARS COV 2 Human Infection Challenge studies (HICS). All were asked to attend two virtual HRA workshops before the first committee meeting (and all did!) and were provided with articles from both sides of the argument for further reading. Given the pandemic lockdown, we met virtually, ensuring broad representation across the UK nations, and that applicants were easily able to attend (of huge help to our review).

Read more+

EMA - Draft IMP documents for comment

'Guideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials' and 'Guideline on the requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials'.

Read more+